Delivery Order HHSN272201700015I-75N93018F00003
Award Date 8/28/18
Potential Completion Date 9/30/20
Potential Value $2.7M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
Rockville, MD 20850, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institute of Allergy and Infectious Diseases issued a delivery order to Bioqual, Inc. on September 4, 2015, with a ceiling value of $2,046,067.33 under the NIAID Animal Models of Infectious Diseases 2010-2017 IDIQ for model refinement in pigtailed macaques. Place of performance is Rockville, Maryland. The order is priced on a cost-plus-fixed-fee basis with an ultimate completion date of April 30, 2017. The work supports preclinical research using non-human primate models for...
- The National Institute of Allergy and Infectious Diseases issued a delivery order to Bioqual, Inc. on March 17, 2017, with a ceiling value of $2,329,868.98 under the NIAID Animal Models of Infectious Diseases 2010-2017 IDIQ. The order calls for assessment of Neisseria gonorrhea and Chlamydia trachomatis co-infection using animal models. Task C34 is a change order covering the period from August 21, 2018 through November 30, 2018. Work is performed in Rockville, Maryland. The order carries...
- <p>The National Institute of Allergy and Infectious Diseases issued a delivery order to Bioqual, Inc. on September 8, 2014, with a ceiling value of $1,840,920.20 under the NIAID Animal Models of Infectious Diseases 2010-2017 IDIQ for model refinement in pig-tailed macaques.</p> <p>Place of performance is Rockville, Maryland. The ultimate completion date is September 28, 2015. The order is priced on a cost, no-fee basis and carries no set-aside.</p>
- The National Institute of Allergy and Infectious Diseases issued a delivery order to Pharmacology Discovery Services Taiwan, LTD. on July 22, 2026, for mouse models of Neisseria gonorrhoeae infection and preclinical models of infectious diseases, with a ceiling value of $621,336. The order is issued under the Pre-Clinical Models of Infectious Diseases IDIQ, a single-award indefinite-delivery contract vehicle valued up to $146.3 million and running through July 2031. The contract supports NIAID's...
- The National Institute of Allergy and Infectious Diseases issued a $1.87 million delivery order to Pharmacology Discovery Services Taiwan, LTD. on July 12, 2024, under the NIAID Preclinical Models of Infectious Diseases 2017-2024 IDIQ for development and supply of a mouse model of Neisseria gonorrhoeae infection. The NIAID Preclinical Models of Infectious Diseases IDIQ supports preclinical infectious disease research by providing animal and animal replacement models for screening and...
- The National Institute of Allergy and Infectious Diseases issued a delivery order to Bioqual, Inc. on November 17, 2011, with a ceiling value of $627,844.82 under the NIAID Animal Models of Infectious Diseases 2010-2017 IDIQ for non-human primate models to support filovirus vaccine efficacy testing. The order is priced on a cost-plus-fixed-fee basis and performance takes place in Rockville, MD. The ultimate completion date is November 30, 2013. Bioqual provides biomedical research services and...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a delivery order valued at $782,160.63 to Bioqual, Inc. for the conduct of Study P218. This unilateral modification (Amendment 2) updates Federal Procurement Data System (FPDS) reporting processes to ensure compliance with a Presidential Memorandum regarding radical transparency about wasteful spending. The contract utilizes a cost-plus-fixed-fee pricing structure with a completion date of June 4, 2024. Bioqual, Inc., a...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a delivery order valued at $3.14 million to Bioqual, Inc. for the conduct of Study P172 under the Simian Vaccine Evaluation Units master IDIQ contract (2013-2020). This cost-plus-fixed-fee delivery order, awarded May 1, 2013, with an ultimate completion date of April 22, 2023, supports NIAID's research infrastructure for evaluating vaccine candidates and countermeasures against infectious diseases using non-human primate...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a delivery order valued at $1.41 million to Bioqual, Inc. for the maintenance of non-human primates in an ABSL2/3 (Animal Biosafety Level 2/3) facility under the Simian Vaccine Evaluation Units (SVEU) program. The contract, awarded April 1, 2020, with an ultimate completion date of March 31, 2027, is structured as a cost-plus-fixed-fee delivery order with no set-aside designation. Bioqual, a for-profit biomedical...
- This is a delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Bioqual, Inc., a for-profit biomedical research services company located in Rockville, Maryland. The contract is for the housing and maintenance of non-human primates for NIAID's Vaccine Research Center (VRC), with a total ceiling value of $2,438,569.73 and a period of performance through July 2, 2024. The contract was awarded on August 8, 2019 and is a firm...